# menarini.com > AI-optimized mirror of menarini.com containing 50 pages totalling 32,164 words of clean markdown content, structured data, and semantic HTML. Original source: https://menarini.com. Last updated: 2026-09-07T02:45:11.813Z. Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG). ## Homepage - [site-root.html](/content/site-root.html) (147 words) ## Articles & Blog Posts - [Local Offices](/content/en-us/countries/local-offices-html.html) (2,660 words) - [Quality comes first - Menarini Group](/content/en-us/quality-comes-first-html.html): Quality is the backbone of Menarini company and drives any activity in development, production, distribution and pharmacovigilance. (993 words) - [Menarini Corporate > Congresses Archive 2024](/content/en-us/congresses/congresses-archive-2024-html.html) (1,718 words) - [Menarini Corporate > Congresses Archive 2025](/content/en-us/congresses/congresses-archive-2025-html.html) (1,949 words) - [Distributors](/content/en-us/countries/distributors-html.html) (1,231 words) - [Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories](/content/en-us/news/news-detail/karyopharm-and-menarini-group-enter-into-exclusive-license-agreement-to-commercialize-nexpovio174-selinexor-in-europe-and-other-key-global-territories-html.html):     Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202.5 Million in Future Milestones, Plus Tiered, Double-digit Royalties on Net Sales   NEWTON, Mass. and FLORENCE, Italy December 21, 2021 – Karyopharm... (1,698 words) - [COVID-19 - Menarini Group](/content/en-us/covid-19-html.html): A. Menarini Diagnostics is committed to fight COVID-19 pandemic providing solutions for timely and decentralized response with early identification of cases. (619 words) - [Netiquette of Menarini Group - Menarini Group](/content/en-us/data-privacy/netiquette-of-menarini-group-html.html): Here are the rules for a correct use of the contents of this site. Read the Netiquette! (1,217 words) - [Manufacturing Sites](/content/en-us/countries/manufacturing-sites-html.html) (325 words) - [About Us](/content/en-us/about-us-html.html): The Menarini Group is present in 140 countries around the world, with an excellent guarantee of quality recognized internationally. (428 words) - [Research Centers](/content/en-us/countries/research-centers-html.html) (226 words) - [Almirall and Menarini sign a licence agreement and commercial alliance for Aclidinium in the majority of European member states and a number of non-EU](/content/en-us/news/news-detail/almirall-and-menarini-sign-a-licence-agreement-and-commercial-alliance-for-aclidinium-in-the-majority-of-european-member-states-and-a-number-of-noneu-html.html):   Almirall and Menarini sign a licence agreement and commercial alliance for Aclidinium in the majority of European member states and a number of non-EU countries Partnership fulfills Almirall's key criteria: territorial complementarity, non-competing portfolio assets, strong primary... (1,092 words) - [Menarini Group Completes Acquisition of Stemline Therapeutics](/content/en-us/news/news-detail/menarini-group-completes-acquisition-of-stemline-therapeutics-html.html):   Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its commercial infrastructure in Europe and other ex-U.S. geographies Following the transaction, Menarini will continue to research ELZONRIS in additional CD123-expressing indications FLORENCE – June 10, 2020 – Menarini Group, a... (777 words) - [DPO contact details of Group Companies without a website - Menarini Group](/content/en-us/data-privacy/dpo-contact-details-of-group-companies-without-a-website-html.html): Privacy Notice on the Processing of Personal Data of Suppliers and Data Subjects. (152 words) - [Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant](/content/en-us/news/news-detail/menarini-group-and-radius-health-announce-global-license-agreement-for-the-development-and-commercialization-of-elacestrant-1-html.html) (1,314 words) - [Our History - Menarini Group](/content/en-us/about-us/our-history-html.html) (277 words) - [Board of Directors - Menarini Group](/content/en-us/about-us/board-of-directors-html.html) (852 words) - [Menarini COM](/content/content/menarini-com-html.html) (344 words) - [Careers - Menarini Group](/content/en-us/careers-html.html): In order to achieve our mission, we constantly seek out the best talent, people who know how to work in a team and who also show initiative, flexibility and enthusiasm. (666 words) - [Cookie Policy - Menarini Group](/content/en-us/data-privacy/cookie-policy-html.html): The website uses cookies to facilitate and personalise the user’s browsing experience; by browsing the Website. (771 words) - [Consumer Healthcare - Menarini Group](/content/en-us/consumer-healthcare-html.html): Our presence in more than 50 countries allows us to help millions of consumer with high quality products. (221 words) - [Monoclonal Antibodies - Menarini Group](/content/en-us/covid-19/monoclonal-antibodies-html.html): Monoclonal Antibodies, a possible treatment: The development of novel antibodies in order to fight back against Covid- 19. (391 words) - [Business Ethics & Compliance Mission - Menarini Group](/content/en-us/about-us/business-ethics-compliance-html.html): Our goal is to design compliance programs and facilitate their implementation and oversight education, counseling and monitoring. (485 words) - [Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million](/content/en-us/news/news-detail/menarini-group-to-acquire-stemline-therapeutics-in-transaction-valued-at-up-to-677-million-html.html): Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its commercial infrastructure in Europe and other ex-U.S. geographies Total potential consideration of $12.50 per share comprising $11.50 cash and $1.00 Contingent Value Right (CVR) FLORENCE and NEW YORK – May 4,... (1,278 words) - [Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant](/content/en-us/news/news-detail/menarini-group-and-radius-health-announce-global-license-agreement-for-the-development-and-commercialization-of-elacestrant-html.html):     Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development Elacestrant further strengthens Menarini’s global oncology portfolio, recently bolstered by the acquisition of Stemline Therapeutics in the U.S. Radius will receive $30M as an upfront payment and up to $320M in additional milestones along with tiered low to mid-teen percentage royalties     ... (1,313 words) - [Data Privacy](/content/en-us/data-privacy-html.html): Policy on the use of website, social networks and other policies. Enter now! (98 words) - [Countries - Menarini Group](/content/en-us/countries-html.html): Menarini is located in various parts of the world: the companies in Florence, Berlin, Barcelona and Singapore are a reference point for the Menarini Group. (170 words) - [Available Positions - Menarini Group](/content/en-us/careers/available-positions-html.html) (188 words) - [NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe](/content/en-us/news/news-detail/newamsterdam-pharma-and-the-menarini-group-sign-licensing-deal-to-commercialize-obicetrapib-in-europe-html.html): Combines NewAmsterdam's lead clinical program obicetrapib with Menarini's deep cardiovascular disease and regional expertise Total deal value of over €1 billion; including €142.5 million upfront payment and committed R&D funding plus potential milestones and double-digit royalties on net product sales in Europe Obicetrapib is a next-generation oral, low-dose and once-daily CETP inhibitor for which promising safety and strong LDL-lowering efficacy has been... (1,069 words) - [Our Recent agreements - Menarini Group](/content/en-us/partnering/our-recent-agreements-html.html) (537 words) - [Our Commitment to Science - Menarini Group](/content/en-us/about-us/our-commitment-to-science-html.html): Fondazione Internazionale Menarini believes in the power of science: we aim to provide quality culture and information to share with the global community. (746 words) - [Mountain view, calif., July 9, 2013 - Vivus announces avanafil partnership with Menarini](/content/en-us/news/news-detail/mountain-view-calif-july-9-2013-vivus-announces-avanafil-partnership-with-menarini-html.html):

VIVUS ANNOUNCES AVANAFIL PARTNERSHIP WITH MENARINI Menarini to Launch and Market SPEDRA in 40 Countries in Europe and Abroad   VIVUS to Receive Upfront Payment Plus Milestones and Royalties Over the Term of the Agreement   MOUNTAIN VIEW, Calif., July 9, 2013: VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into a License and Commercialization Agreement and a Supply Agreement with Menarini and its wholly-owned subsidiary...

(972 words) - [Careers at Menarini](/content/en-us/careers/careers-at-menarini-html.html) (510 words) - [Menarini Corporate > Congresses](/content/en-us/congresses-html.html) (1,877 words) - [Menarini Corporate > Careers > Careers in Oncology](/content/en-us/careers/careers-in-oncology-html.html): In order to achieve our mission, we constantly seek out the best talent, people who know how to work in a team and who also show initiative, flexibility and enthusiasm. (124 words) - [Our stories - Menarini Group](/content/en-us/careers/our-stories-html.html) (64 words) - [Cough, Cold & Allergy - Menarini Group](/content/en-us/consumer-healthcare/cough-cold-allergy-html.html): Cough, Cold, and allergy all affect your respiratory system, which can make it hard to breathe. Each condition has key symptoms that set them apart. (135 words) - [Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA](/content/en-us/news/news-detail/menarini-ricerche-to-sponsor-cancer-trial-in-acute-myeloid-leukemia-in-usa-html.html): Pomezia, Italy, August 6, 2018. Menarini Ricerche, a company of the Menarini Group, announced today that the sponsorship of the ongoing Phase I/II study that is investigating MEN1703/SEL24 for the treatment of patients with relapsed/refractory (R/R) AML in the USA has been transferred from Selvita to Menarini Ricerche on June 30th 2018. Selvita S.A. and Menarini Group entered into a global licensing agreement for SEL24/1703 on March 28, 2017. Menarini Ricerche has assumed full... (487 words) - [Contact Us - Menarini Group](/content/en-us/contact-us-html.html): Do you want to get in touch with the Menarini Group? Enter and write us using our official references. (74 words) - [The recruiting process - Menarini Group](/content/en-us/careers/the-recruiting-process-html.html): To work at Menarini is an opportunity to improve the quality of life for everyone, for the common good, for public health. (398 words) - [Lifestyle OTCs - Menarini Group](/content/en-us/consumer-healthcare/lifestyle-otcs-html.html): Health of the urinary tract is a delicate aspect that a man should know, especially with the passing of the years to fully cultivate his own well-being. (158 words) - [Menarini Group - Quality comes first](/content/en-us-html.html): The Menarini Group distinguishes itself by quality therapeutics and diagnostics solutions, ethics, innovation, people centricity and sustainability. (134 words) - [Vitamins, Minerals & Supplements - Menarini Group](/content/en-us/consumer-healthcare/vitamins-minerals-supplements-html.html): Vitamins and minerals are essential substances that our bodies need to develop and function normally. (72 words) - [Gastrointestinals - Menarini Group](/content/en-us/consumer-healthcare/gastrointestinals-html.html): An imbalance in this system can be related to a variety of symptoms and discomfort worsening the quality of life of millions of people in the world, everyday. (81 words) - [Our Roots - Menarini Group](/content/en-us/about-us/our-roots-html.html): Menarini has a story of passion, quality, and a sense of union and it is also strongly tied to the artistic and cultural heritage of the city of Florence. (387 words) - [Transparency in healthcare - Menarini Group](/content/en-us/about-us/business-ethics-compliance/transparency-in-healthcare-html.html): We are firmly focused on our mission and take our responsibility very seriously regarding the need for a transparent way of acting. (294 words) - [Analgesics - Menarini Group](/content/en-us/consumer-healthcare/analgesics-html.html): Menarini is improving its own ability to understand and manage pain, staying connected with people, continuing our education and offering innovative solutions. (78 words) - [Sustainability - Menarini Group](/content/en-us/about-us/sustainability-html.html) (264 words) - [Executive Team - Menarini Group](/content/en-us/about-us/executive-team-html.html) (103 words) ## Resources - [Full Page Index](/index.html): Browse all cached pages with rich metadata - [About This Cache](/about.html): Methodology, technical details, and usage guidelines - [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery - [Robots.txt](/robots.txt): Crawler directives - [AgentSite Network](https://agentsite.network/network.html): Public index of AgentSites and their machine-readable resources